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Recent developments in medical and surgical subspecialties have contributed to improved quality of life in patients with spina 
bifida (SB). Despite the challenges of chronic pain, spinal abnormality, gait abnormalities, loss of urinary, and fecal continence, 
female patients can become pregnant. Provision of obstetrics and/or surgical care to patients with SB may become more common 
as more patients survive to adulthood. Preconception counseling, antenatal care, obstetrics, and other specialized care are 
essential components of optimal management of these patients. We report the obstetric and anesthetic challenges encountered 
in a primigravida with SB occulta and a spinal cord stimulator who had caesarean delivery. Effective communication between the 
patient, obstetricians, and anesthetists, as well as planned and coordinated care, ensured a successful feto‑maternal outcome.
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Introduction
Spina bifida (SB) is a neural tube defect (NTD) caused by 
failure of closure of the neural arch during embryogenesis. 
It may be associated with neural, sensory, and motor losses, 
orthopedic impairments, bladder and bowel dysfunction, 
and occasional cognitive impairments.[1] By estimate, NTDs 
affect 300,000 newborn babies globally, with SB accounting 
for about 50% of cases.[2]
Although mortality rate of up to 60% was previously reported 
in patients with SB by adulthood,[3] advances in medical and 
surgical managements have raised survival to adulthood to 
the current level of 80%.[4]
Pregnancy in a patient with SB is fraught with many 
problems including 4% higher risk of delivering a baby with 
NTD compared with 0.1%–0.3% in the general population,[5] 
worsening of bowel and bladder dysfunction, and movement 
disorders among others. Literature on the obstetric and 
anesthetic management of parturients with SB is virtually 
nonexistent in our environment. We present our experience 
on preconception counseling, antenatal care, and successful 
Caesarean delivery in a primigravida with SB who had multiple 
corrective spine surgeries and a spinal cord stimulator (SCS).
Case Report
The patient was a 33-year-old married nulliparous woman 
with SB occulta who visited our hospital to enquire about 
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preconception care and obstetrics care services for patients 
with NTDs. Diagnosis of SB occulta was made in her teenage 
years and she had history of urinary and fecal incontinences, 
chronic constipation, chronic pain, and progressive loss of 
sensory and motor functions involving both lower limbs 
resulting in lower limbs’ weakness and gait abnormalities.
She had multiple corrective spinal surgeries, the most 
recent one being 3 years previously and involved spinal 
re-exploration and de-tethering, L2–L5 laminectomy, lipoma 
excision, filum sectioning, duraplasty, and insertion of spinal 
cord stimulation electrodes [Figures 1-3]. The inserted 
electrodes over the thoracic and sacral epidural space were 
for control of chronic lower limb pain and neurogenic bladder, 
respectively. She learnt how to perform essential skills such 
as self-catheterization, manual rectal evacuation, and soap 
and water enema to relieve constipation. She was also on 
intermittent prophylactic laxatives to relieve constipation. 
Despite gait abnormality, she was ambulating with the aid 
of either crutches or a walking frame.
Clinical examination revealed a healthy young woman with 
intact cranial nerves, normal power, tone and reflexes in the 
upper limbs but mild hypo-tonia and hypo-reflexia, muscle 
atrophy, and patchy loss of touch sensations in both lower 
limbs up to the upper thirds of her thighs. Power in the right 
and left lower limbs were 3 and 4, respectively. There was a 
longitudinal surgical scar over the lower back and an oblique 
scar along the superior edge of the glutei muscles bilaterally, 
with the implantable pulse generator on the right side.
That pregnancy, when achieved, might be associated with 
high risk of delivering a baby with the same congenital 
abnormality, recurrent urinary tract infections (UTIs), 
increasing bowel and bladder dysfunction, and worsening 
of back and lower limb pain was part of the preconception 
counseling offered to the patient. She was immediately 
commenced on high-dose folic acid and advised to re-present 
when she conceives.
Six months after counseling and commencement of high-dose 
folic acid, she presented with an ultrasound confirmation of 
an 8-week intrauterine gestation. Laboratory investigations 
were within normal limits at antenatal booking. She was 
encouraged to continue high-dose folic acid and hematinics. 
Anomaly scan performed at 22 weeks was normal. The 
SCS was deactivated and remained so throughout the 
remaining period of pregnancy. The patient had prophylactic 
nitrofurantoin from the second trimester up to 34 weeks 
to reduce the incidence of recurrent UTIs. Delivery options 
were discussed and an elective Caesarean section at term 
was decided upon in view of her neuromuscular problems. 
Options of anesthesia were also discussed. An episode of UTI 
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guided the treatment. Her renal function remained normal 
throughout pregnancy.
At 38 weeks’ gestation, she was delivered of a live male infant 
through an elective Caesarean section under opioid-free 
general anesthesia with ketamine used as an induction 
agent and pancuronium bromide to intubate the trachea and 
maintain muscle relaxation. Effective communication during 
the antenatal and perioperative periods ensued between the 
patient, obstetrics, and the anesthesiology teams in taking 
this decision.
Postoperative analgesia was achieved by continuous 
ketamine infusion at 12 mg/h through an infusion pump and 
continuous wound infusion with plain bupivacaine (0.125%) 
2 mL/h delivered with Beeline postop pain control pump (LOT 
CP15669, REF BL 1D002SK2-CP, USA) and acetaminophen 
infusion 600 mg 8 hourly for 3 days, with good pain control 
achieved throughout. Postoperative compression stockings, 
anticoagulant, combined with early ambulation in the 
post-operative period, were instituted to prevent development 
of deep vein thrombosis, a common complication in patients 
with SB due to restricted mobility. Disturbing spastic 
contraction of the lower limbs was prominent on the third 
postoperative day but it responded to baclofen tablets.
The newborn underwent a thorough physical examination 
with no abnormalities detected. She was discharged home 
on the sixth postoperative day. She attended postnatal 
visits at the second and sixth week postpartum and had no 
complaints.
Discussion
Worldwide, pregnancy in SB patients is a relatively uncommon 
occurrence, and to the best of our knowledge, this is the 
first report of successful obstetric care of a parturient with 
SB occulta and SCS in this environment.
This case highlighted the importance of immediate and 
thorough physical examination of all newborn for early 
detection of congenital abnormalities, the necessity of 
preconception care provision, including preconception folic 
acid, the challenges that could occur during pregnancy and 
delivery, as well as the need for multidisciplinary management 
of parturients with SB to achieve good outcome.
In view of the increased risk of giving birth to a child 
with similar abnormality, this patient was commenced on 
preconception high-dose folic acid which has been found 
to lower this risk, as dietary folic acid deficiency has been 
implicated in the development of NTDs.
This patient had a neurogenic bladder, which is common in 
patients with SB and the antenatal period was complicated 
by UTI. Prophylactic nitrofurantoin and intermittent 
catheterization may have helped to limit the occurrence of 
UTI to just one episode. Use of prophylactic nitrofurantoin 
is encouraged in patients with increased risk of UTI during 
pregnancy.[6]
She also had an SCS implanted for neurogenic bladder 
and chronic lower limb pain. This device is helpful in the 
management of various disorders including urinary tract and 
bowel dysfunction, spinal injury, and chronic pain syndromes, 
and there have been reports of pregnancies in patients with 
the device. The risks posed to the fetus by the SCS remain 
unknown, and there is no consensus regarding its safety 
during pregnancy. While some clinicians have postulated that 
SCS, through electromagnetic field force, could potentially 
compromise the placenta and developing fetus,[7] others have 
reported on its safe use without any untoward effect on the 
pregnant woman or her baby.[8,9] It has thus been advised 
that activation or deactivation during pregnancy should be 
individualized.[10]
Patients with SB have an increased predisposition to preterm 
labor[11] possibly due to UTIs or undetected coexisting 
abnormalities of the genital tract such as bicornuate uterus.[4] 
This complication, however, did not occur in this patient.
Although there are reports of safety of vaginal deliveries 
among women with SB,[11] our patient was counseled for, 
and had, an elective Caesarean section at term because 
she was a primigravida with an untried pelvis, wasted 
muscles of the lower limbs, gait abnormalities, and previous 
multiple spinal surgeries. This helped to avoid potential 
prolongation of labor and difficult delivery that could result 
from suspected compromised pelvis. Our chosen mode 
of delivery agrees with preferences of some authors for 
Caesarean section in patients with SB[12] although other 
authors recommend Caesarean section only for obstetric 
indications.[5]
Generally speaking, establishing regional anesthesia in 
patients with SB is challenging due to the abnormality of 
the spine and possibility of tethered cord which may result 
in iatrogenic cord injury.[13,14] Regional anesthesia was not 
favored in this patient due to the high likelihood of fibrosis 
within the peri-spinal spaces from her multiple spine 
surgeries. Moreover, she had SCS leads in the epidural space 
overlying T9–11 with the generator in the gluteal region. This 
lead can migrate if, during neuroaxial block, the advancing 
tip of the needle impinges on the connecting wire.
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Preconception care and multidisciplinary care involving 
obstetrician, neurosurgeon, physiotherapist, neonatologist, 
and anesthetist contributed to the good outcome observed 
in this patient.
Conclusion
As more patients with SB are surviving to adulthood, 
maternity care providers will increasingly encounter pregnant 
parturients with this congenital abnormality. There is a need 
for healthcare practitioners to be familiar with obstetric, 
urologic, surgical, and anesthetic challenges involved in the 
care of these patients and their preconception care needs 
to improve outcomes and reduce the risk of recurrence in 
their offspring.
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